You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. SMALL MOLECULE ANTAGONISTS OF PF FOR THE TREATMENT AND PREVENTION OF HIT

    SBC: FOX CHASE CHEMICAL DIVERSITY CENTER INC.            Topic: NHLBI

    DESCRIPTION provided by applicant We have discovered the first ever inhibitors of PF a platelet protein central to the pathophysiology of heparin induced thrombocytopenia HIT Heparin is a naturally occurring anticoagulant that prevents the formation of clots and extension of existing clots within the vasculature and major medical applications of heparin include dialysis cardiac catheteri ...

    STTR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  2. Small Molecule Inhibitors of HIV Nef Virulence Factor for Treatment of HIV AIDS

    SBC: FOX CHASE CHEMICAL DIVERSITY CENTER INC.            Topic: 100

    DESCRIPTION provided by applicant While HIV AIDS can be managed with antiretroviral drugs these agents do not clear the virus and require life long administration Recently we discovered a completely new class of compounds that interfere with the HIV virulence factor called Nef This viral protein is critical to HIV replication in vivo immune escape of HIV infected cells and AIDS progre ...

    STTR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  3. Detection Avoidance System for Submarines (DASS)

    SBC: DANIEL H WAGNER ASSOCIATES INC            Topic: N14AT016

    In this STTR, Daniel H. Wagner Associates, together with the University of Michigan (UM), will develop a Detection Avoidance System for Submarines (DASS). The proposed DASS is a set of software modules which solves the probabilistic passive sonar equation (PSE) using given environmental acoustic data, assesses submarine vulnerability based on intelligence about potential threat ASW assets, recomme ...

    STTR Phase II 2016 Department of DefenseNavy
  4. An Embedded Health Monitoring System for Determining Readiness of Electronic Components

    SBC: NOKOMIS INC            Topic: MDA14T001

    The MDA is in need of a robust, holistic Electronics Health Monitoring (EHM) solution that can address mission readiness concerns. Nokomis solution to this problem provides unique information to operators and maintainers and a more complete picture of component readiness. Nokomis novel methodologies for determining device health, whereby changes in unintended RF emissions signatures are leverage ...

    STTR Phase II 2016 Department of DefenseMissile Defense Agency
  5. Real Time 3-D Modeling and Immersive Visualization for Enhanced Soldier Situation Awareness

    SBC: Carnegie Robotics LLC            Topic: A12aT003

    We propose a rapid mapping and 3-D visualization system especially suited for inside buildings, tunnels, urban canyons, and other environments where GPS may be poor or not available. The system--which was fully demonstrated in our Phase I effort-- includes mobile Sensor Nodes that wirelessly supply compressed 3D range data and color imagery to a central Fusion Node. The Fusion Node runs 3D recon ...

    STTR Phase II 2014 Department of DefenseArmy
  6. Autonomous UAV Aerodynamic Performance Analysis for the Near-Ship Environment

    SBC: COMBUSTION RESEARCH & FLOW TECHNOLOGY INC            Topic: N07T004

    The overall goal of this STTR program is to develop an efficient, high-fidelity, CFD-based design tool for the simulation of ship-board flight testing of autonomous UAV systems. In the first phase of this program, an overall flight simulation framework that employs a modular approach to the flight simulation problem was developed. Phase II of the program demonstrated a fully coupled aircraft/ship ...

    STTR Phase II 2014 Department of DefenseNavy
  7. Novel Extensible Design Approaches for Advanced Aircraft Composite Structural Architectures (MSC P4168)

    SBC: MATERIALS SCIENCES LLC            Topic: ST13A006

    Among the factors that inhibit the use of composite materials in both general aviation aircraft and DoD platforms are the relatively high cost of engineering and certification. Unless manufacturers control risk when introducing new or advanced materials and processes for aircraft, the potential benefits will be lost to the industry. For small commercial applications the problem is compounded by ...

    STTR Phase II 2014 Department of DefenseDefense Advanced Research Projects Agency
  8. Developing Intravesical Liposomes for Interstitial Cystitis

    SBC: Lipella Pharmaceuticals Inc.            Topic: NIDDK

    DESCRIPTION (provided by applicant): Lipella Pharmaceuticals Inc. (Pittsburgh, PA) is a clinical-stage pharmaceutical company specializing in intravesical therapies for urinary bladder dysfunctions. Lipella is submitting a research proposal to the Small Business Technology Transfer program titled Developing Intravesical Liposomes for Interstitial Cystitis . The project proposes to evaluate the sa ...

    STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  9. An Early-Phase Clinical Trial Evaluating ABC294640 in Patients with Refractory/Re

    SBC: Apogee Biotechnology Corporation            Topic: 102

    DESCRIPTION provided by applicant Diffuse large B cell lymphoma DLBCL represents one of the most common variants of Non Hodgkinandapos s lymphoma NHL and oncogenic herpesviruses EBV and KSHV are the etiologic agents for the majority of these tumors in patients over or those infected with the human immunodeficiency virus HIV Despite modest improvements in outcomes for patients rece ...

    STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  10. Developing Intravesical Liposomes for Interstitial Cystitis

    SBC: Lipella Pharmaceuticals Inc.            Topic: NIDDK

    DESCRIPTION provided by applicant Lipella Pharmaceuticals Inc Pittsburgh PA is a clinical stage pharmaceutical company specializing in intravesical therapies for urinary bladder dysfunctions Lipella is submitting a research proposal to the Small Business Technology Transfer program titled andquot Developing Intravesical Liposomes for Interstitial Cystitisandquot The project proposes to e ...

    STTR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government